Skip to the page

Data / Form D filings / Vin-37 Solaris Vaccines, LLC

Vin-37 Solaris Vaccines, LLC: Form D filing

Vin-37 Solaris Vaccines, LLC, a company in Fayetteville, AR, filed a Form D with the SEC in 2023. The latest, on April 21, 2023, reports $35,000 sold of a $500,000 offering to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
535 W. RESEARCH CENTER BLVD., STE. 135, Fayetteville, AR, 72701
Phone
(479) 521-2592
Industry
Other
Entity type
Limited Liability Company
Incorporated in
Arkansas
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b), Securities Act section 4(a)(5)
SEC identifier (CIK)
1974784

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 21, 2023New notice$500,000$35,000$465,0005Apr 7, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Mark Calvin WagstaffExecutive Officer
Robert Calvin GoforthExecutive Officer

Other companies in Arkansas that filed recently

Every Form D from the week of Apr 17, 2023 · All recent filings in Arkansas · All recent Other filings

Read from SEC EDGAR. Amount sold is what Vin-37 Solaris Vaccines, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.